Ignite Creation Date:
2024-05-06 @ 5:12 PM
Last Modification Date:
2024-10-26 @ 2:24 PM
Study NCT ID:
NCT05228015
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-17
First Post:
2022-01-07
Brief Title:
Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects With Advanced Solid Tumors
Sponsor:
Ikena Oncology
Organization:
Ikena Oncology
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Solid Tumors Adult |
| Solid Tumor |
| Malignant Pleural Mesothelioma MPM |
| Epithelioid Hemangioendothelioma EHE |
| NF2 Deficient Mesothelioma |
| Other NF2 Deficient Solid Tumors and Solid Tumors With YAP1TAZ Fusion Genes |
| NF2 Deficiency |
| YAP1 or TAZ Gene Fusions |